article · 2007
2106 POSTER Randomized clinical comparison of weekly or every-3-week 130-nanometer albumin-bound paclitaxel vs. every-3-week docetaxel as first-line therapy in patients with metastatic breast cancer
2 citationsDOI: https://doi.org/10.1016/s1359-6349(07)70868-6